# DigitalBridge Group, Inc.: financial statements, quarterly

DBRHP · OTC · CIK 1679688 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dbrhp.md) · [Financials](/companies/dbrhp/financials.md) · [Filings](/companies/dbrhp/filings.md) · [Insiders](/companies/dbrhp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dbrhp/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [263](/filings/0001679688-25-000017.md) | [350](/filings/0001679688-25-000017.md) | [74.4](/filings/0001679688-25-000043.md) | [390](/filings/0001679688-25-000084.md) | [76.1](/filings/0001679688-25-000100.md) | [66.2 d](/filings/0001679688-26-000021.md) | [45.4](/filings/0001679688-26-000056.md) | [(3.2)](/filings/0001679688-26-000115.md) | [3.8](/filings/0001679688-25-000100.md) | [47.9 d](/filings/0001679688-26-000021.md) | [72.2](/filings/0001679688-26-000056.md) | [509](/filings/0001679688-26-000115.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.1](/filings/0001679688-24-000110.md) | [(3.9) d](/filings/0001679688-26-000021.md) | [1.2](/filings/0001679688-25-000043.md) | [(0.0)](/filings/0001679688-25-000084.md) | [0.9](/filings/0001679688-25-000100.md) | [0.8 d](/filings/0001679688-26-000021.md) | [0.3](/filings/0001679688-26-000056.md) | [0.8](/filings/0001679688-26-000115.md) | [(0.2)](/filings/0001679688-25-000100.md) | [4.9 d](/filings/0001679688-26-000021.md) | [(0.0)](/filings/0001679688-26-000056.md) | [0.9](/filings/0001679688-26-000115.md) |
| Net income | $m | [276](/filings/0001679688-25-000017.md) | [115](/filings/0001679688-25-000017.md) | [(29.6)](/filings/0001679688-25-000043.md) | [91.4](/filings/0001679688-25-000084.md) | [13.8](/filings/0001679688-25-000100.md) | [(5.1) d](/filings/0001679688-26-000021.md) | [13.8](/filings/0001679688-26-000056.md) | [31.6](/filings/0001679688-26-000115.md) | [31.4](/filings/0001679688-25-000100.md) | [65.1 d](/filings/0001679688-26-000021.md) | [20.0](/filings/0001679688-26-000056.md) | [227](/filings/0001679688-26-000115.md) |
| Diluted EPS | $ per share | [1.51](/filings/0001679688-25-000017.md) | [0.58](/filings/0001679688-25-000017.md) | [(0.28)](/filings/0001679688-25-000043.md) | [0.44](/filings/0001679688-25-000084.md) | [(0.01)](/filings/0001679688-25-000100.md) | not reported | [(0.01)](/filings/0001679688-26-000056.md) | [0.10](/filings/0001679688-26-000115.md) | [0.09](/filings/0001679688-25-000100.md) | not reported | [0.03](/filings/0001679688-26-000056.md) | [1.15](/filings/0001679688-26-000115.md) |
| Basic EPS | $ per share | [1.60](/filings/0001679688-25-000017.md) | [0.61](/filings/0001679688-25-000017.md) | [(0.28)](/filings/0001679688-25-000043.md) | [0.44](/filings/0001679688-25-000084.md) | [(0.01)](/filings/0001679688-25-000100.md) | not reported | [(0.01)](/filings/0001679688-26-000056.md) | [0.10](/filings/0001679688-26-000115.md) | [0.09](/filings/0001679688-25-000100.md) | not reported | [0.03](/filings/0001679688-26-000056.md) | [1.15](/filings/0001679688-26-000115.md) |

- Revenue: us-gaap:Revenues
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [380](/filings/0001679688-24-000110.md) | [345](/filings/0001679688-26-000021.md) | [247](/filings/0001679688-25-000043.md) | [261](/filings/0001679688-25-000084.md) | [294](/filings/0001679688-25-000100.md) | [302](/filings/0001679688-26-000115.md) | [350](/filings/0001679688-26-000056.md) | [341](/filings/0001679688-26-000115.md) | [358](/filings/0001679688-25-000100.md) | [383](/filings/0001679688-26-000115.md) | [411](/filings/0001679688-26-000056.md) | [508](/filings/0001679688-26-000115.md) |
| Total assets | $m | [6,872](/filings/0001679688-23-000119.md) | [3,563](/filings/0001679688-25-000017.md) | [3,464](/filings/0001679688-24-000066.md) | [3,502](/filings/0001679688-24-000096.md) | [3,543](/filings/0001679688-24-000110.md) | [3,513](/filings/0001679688-26-000021.md) | [3,439](/filings/0001679688-25-000043.md) | [3,409](/filings/0001679688-25-000084.md) | [3,491](/filings/0001679688-25-000100.md) | [3,419](/filings/0001679688-26-000115.md) | [3,334](/filings/0001679688-26-000056.md) | [3,764](/filings/0001679688-26-000115.md) |
| Total liabilities | $m | [3,847](/filings/0001679688-23-000119.md) | [1,053](/filings/0001679688-25-000017.md) | [941](/filings/0001679688-24-000066.md) | [1,040](/filings/0001679688-24-000096.md) | [1,037](/filings/0001679688-24-000110.md) | [1,022](/filings/0001679688-26-000021.md) | [974](/filings/0001679688-25-000043.md) | [958](/filings/0001679688-25-000084.md) | [971](/filings/0001679688-25-000100.md) | [969](/filings/0001679688-26-000115.md) | [915](/filings/0001679688-26-000056.md) | [1,117](/filings/0001679688-26-000115.md) |
| Long-term debt | $m | not reported | [372](/filings/0001679688-25-000017.md) | [367](/filings/0001679688-24-000066.md) | [295](/filings/0001679688-24-000096.md) | [296](/filings/0001679688-24-000110.md) | [296](/filings/0001679688-26-000021.md) | [297](/filings/0001679688-25-000043.md) | [298](/filings/0001679688-25-000084.md) | [328](/filings/0001679688-25-000100.md) | [299](/filings/0001679688-26-000115.md) | [299](/filings/0001679688-26-000056.md) | [292](/filings/0001679688-26-000115.md) |
| Shareholders' equity | $m | [1,691](/filings/0001679688-23-000119.md) | [1,811](/filings/0001679688-25-000017.md) | [1,818](/filings/0001679688-24-000066.md) | [1,972](/filings/0001679688-24-000096.md) | [1,980](/filings/0001679688-24-000110.md) | [1,959](/filings/0001679688-26-000021.md) | [1,961](/filings/0001679688-25-000043.md) | [2,019](/filings/0001679688-25-000084.md) | [2,052](/filings/0001679688-25-000100.md) | [2,107](/filings/0001679688-26-000115.md) | [2,107](/filings/0001679688-26-000056.md) | [2,345](/filings/0001679688-26-000115.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [100 d](/filings/0001679688-24-000110.md) | [41.6 d](/filings/0001679688-26-000021.md) | [(27.0)](/filings/0001679688-25-000043.md) | [22.5 d](/filings/0001679688-25-000084.md) | [35.9 d](/filings/0001679688-25-000100.md) | [28.7 d](/filings/0001679688-26-000021.md) | [50.3](/filings/0001679688-26-000056.md) | [77.0 d](/filings/0001679688-26-000115.md) | [56.5 d](/filings/0001679688-25-000100.md) | [75.6 d](/filings/0001679688-26-000021.md) | [(40.0)](/filings/0001679688-26-000056.md) | [87.2 d](/filings/0001679688-26-000115.md) |
| Capital expenditure | $m | [0.0 d](/filings/0001679688-24-000110.md) | [0.0 d](/filings/0001679688-26-000021.md) | [3.1](/filings/0001679688-25-000043.md) | [0.3 d](/filings/0001679688-25-000084.md) | [0.0 d](/filings/0001679688-25-000100.md) | [0.3 d](/filings/0001679688-26-000021.md) | [0.3](/filings/0001679688-26-000056.md) | [0.6 d](/filings/0001679688-26-000115.md) | [0.4 d](/filings/0001679688-25-000100.md) | [0.1 d](/filings/0001679688-26-000021.md) | [0.1](/filings/0001679688-26-000056.md) | [0.0 d](/filings/0001679688-26-000115.md) |
| Dividends paid | $m | [1.6 d](/filings/0001679688-24-000110.md) | [1.6 d](/filings/0001679688-26-000021.md) | [1.6](/filings/0001679688-25-000043.md) | [1.7 d](/filings/0001679688-25-000084.md) | [1.7 d](/filings/0001679688-25-000100.md) | [1.7 d](/filings/0001679688-26-000021.md) | [1.7](/filings/0001679688-26-000056.md) | [1.8 d](/filings/0001679688-26-000115.md) | [1.8 d](/filings/0001679688-25-000100.md) | [1.8 d](/filings/0001679688-26-000021.md) | [1.8](/filings/0001679688-26-000056.md) | [1.8 d](/filings/0001679688-26-000115.md) |
| Share repurchases | $m | not reported | [0.0 d](/filings/0001679688-25-000017.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [162](/filings/0001679688-23-000119.md) | [158](/filings/0001679688-24-000066.md) | [158](/filings/0001679688-24-000096.md) | [171](/filings/0001679688-24-000110.md) | [161](/filings/0001679688-25-000043.md) | [172](/filings/0001679688-25-000084.md) | [172](/filings/0001679688-25-000100.md) | [172](/filings/0001679688-26-000056.md) | [173](/filings/0001679688-26-000115.md) | [179](/filings/0001679688-25-000100.md) | [180](/filings/0001679688-26-000056.md) | [182](/filings/0001679688-26-000115.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 187,495,281 at 2026-07-31, from the cover of the [10-Q filed 2026-08-04](/filings/0001679688-26-000115.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.